Teachers Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-79,114
Closed -$3.62M 3082
2017
Q4
$3.62M Buy
79,114
+5,105
+7% +$255K ﹤0.01% 1514
2017
Q3
$3.32M Sell
74,009
-246
-0.3% -$8.39K ﹤0.01% 1557
2017
Q2
$2.22M Buy
74,255
+9,890
+15% +$244K ﹤0.01% 1759
2017
Q1
$1.43M Buy
64,365
+3,531
+6% +$75.7K ﹤0.01% 1958
2016
Q4
$1.15M Buy
60,834
+6,643
+12% +$163K ﹤0.01% 2108
2016
Q3
$1.63M Buy
54,191
+1,643
+3% +$51.1K ﹤0.01% 1798
2016
Q2
$2.02M Buy
52,548
+44,017
+516% +$1.83M ﹤0.01% 1651
2016
Q1
$325K Sell
8,531
-1,200
-12% -$41.8K ﹤0.01% 2571
2015
Q4
$428K Sell
9,731
-29,800
-75% -$1.48M ﹤0.01% 2499
2015
Q3
$1.61M Buy
39,531
+11,552
+41% +$507K ﹤0.01% 1701
2015
Q2
$1.49M Buy
27,979
+21,540
+335% +$1.14M ﹤0.01% 1877
2015
Q1
$391K Buy
+6,439
New +$312K ﹤0.01% 2576

Other funds holding JUNO

Teachers Advisors's JUNO Position: Q1 2018 in Review

Teachers Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 79,114 shares — an estimated $3.62M sold.

Teachers Advisors first reported a position in JUNO in Q1 2015 and held it in 12 quarters. The position peaked at $3.62M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Teachers Advisors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Teachers Advisors sold 79,114 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $3.62M.
  • Teachers Advisors first reported a position in Juno Therapeutics, Inc. in Q1 2015 and held it in 12 quarters.
  • Teachers Advisors's Juno Therapeutics, Inc. position peaked at $3.62M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Teachers Advisors's 13F filing for Q1 2018, filed 14 May 2018.